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Abstract 
Background: The aim of study was to determine the effect of gradual 
reduction in sodium dialysate on occurrence of muscular cramp, and 
the serum level of calcium and magnesium in patients undergoing 
hemodialysis. 
Methods: This triple-blinded cross-over clinical trial was conducted on 
56 hemodialysis patients. After random allocation of patients into 
group A by the routine method (fixed sodium dialysate) and group B 
with gradual reduction in sodium dialysate, they underwent a 3-session 
dialysis. After one week of dialysis through routine method (wash out), 
patients underwent 3-session dialysis in group B by routine method and 
in group A by gradual reduction in sodium dialysate. Occurrence of 
muscular cramp was recorded by using a check list. Patients, serum 
level of calcium and magnesium before and after intervention was 
measured. Descriptive statistics indices and inferential statistics tests 
(repeated measures Analysis of variance) were used. 
Results: The rate of muscular cramp in routine method was 3.8% in 
one muscle, 1.9% in two or more muscles, and in the method of 
gradual reduction of sodium dialysate was 1.9% in one muscle, and 
7.5% in two or more muscles. The mean difference of plasma calcium 
and magnesium before and after the dialysis with routine method was 
0.43 and 0.26, respectively, and in the method of gradual reduction of 
sodium dialysate was 0.45 and 0.34. In this study no significant 
difference was observed for the rate of occurrence of muscular cramp 
and serum level of calcium and magnesium between two methods. 
Conclusions: The results showed that gradual reduction of sodium 
dialysate, has no effect on occurrence of muscular cramp during 
dialysis, serum level of calcium and magnesium in hemodialysis 
patients. Further investigations are needed to better understand the 
exact effect of this method, and also eliminate the study limitations. 
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Introduction 
Chronic renal failure (CRF) is the irreversible defect in 
kidney’s function which occurs progressively, and most of the 
patients finally need permanent hemodialysis.1 Renal 
replacement therapy in end stage renal disease (ESRD) is the 
major and growing part of health costs in various countries. 
Mean prevalence of renal failure in the world is 465 in one 
million individuals; however, this rate reached 680 in one 
million individuals in Iran, which is higher than global 
average.2 This therapeutic approach has complications despite 
many advantages, which result in discomfort for patients and 
reduction in efficiency of dialysis, and also these complications 
increase the workload of nurses and physicians, and add a lot of 
costs to treatment system, and reduce acceptance of patients to 
perform regular program of dialysis. Therefore, control and 
prevention of these complications is of most important.3,4 
One of the common complications during hemodialysis is 
muscular cramp.5 Muscular cramp is a long-lasting 
complication in which painful contractions occurred in lower 
limbs, and affect other organs. This complication is occurred 
during dialysis, and might adversely affect quality of life of 
hemodialysis patients and the severe complications might occur 
in some patients, and leads to discontinuation of dialysis.6-8 
In the conducted study in London at 2011 the most 
common symptoms reported were intradialytic hypotension 
(76%) and muscular cramp (74%), and the main reason of 
muscular cramp during hemodialysis is not known to date.9 
Muscular cramp is a bothering problem and is one of the 
reasons of low efficiency of dialysis. 
This complication has many effects on quality of 
hemodialysis and is one of the reasons for lack of adoption to 
hemodialysis.10 Since this complication leads to early 
discontinuation of hemodialysis, prevention of this 
complication can be one of the greatest problems of staff at 
dialysis ward especially nurses.11 Electrolyte imbalance and 
disturbances in mineral metabolism such as reduction in 
calcium and magnesium level can increase muscular cramps.12 
One study showed that calcium and phosphorus level of saliva 
in dialysis patients is higher, but has no association with level 
of calcium and phosphorus in serum of dialysis patients.13 
Many recent studies showed deficiency of electrolytes such 
as calcium, magnesium, and vitamin B in most individuals with 
painful spasm of calf, on the other hand, several clinical trials 
were conducted to investigate the effect of therapeutic 
supplements such as calcium and magnesium and vitamins in 
improvement of muscular cramps. As a result of these 
treatments, partial but not fully improvement has been 
reported.14-16 
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In addition, magnesium plays an important role in 
calcification of vessels in patients with chronic renal failure 
and pre-dialysis caused by diabetes.17,18 For prevention or 
attenuation of muscular cramp in hemodialysis various 
methods are used such as change in dialysis time, change in 
dialysate temperature, programmed nursing care, gradual 
reduction in sodium dialysate, and change in ultra-filtration and 
also linear and stepped profile.19-23 
One of the methods used to reduce complications during 
dialysis is using dialysis through sodium profile. One of the 
benefits of this profile is that using high concentration sodium 
at the initiation of dialysis causes facilitation in transforming 
water from intracellular space to intravascular space, and by 
maintenance of intravascular volume, reduced blood pressure 
and muscular cramp are prevented.24 One study recommended 
using sodium profile and ultra-filtration in reducing muscular 
cramp during dialysis as a simpler and inexpensive method 
than routine method.25 
On the other hand, a prospective study on pregnant women 
showed that despite the effect of mode of feeding on 
occurrence of cramp, consumption of magnesium in patients 
with magnesium deficiency is useful in prevention and 
improvement of cramp.26 Some studies reported reduction in 
blood level of electrolytes such as calcium is a leading cause of 
spasm, and also stated that partial improvement after calcium-
therapy occurs as reduction in recurrence of muscular cramp.16,27-28 
There is no consensus on the most effective method for 
prevention of muscular cramp during dialysis. Due to 
abovementioned findings, this study aimed to determine the 
effect of gradual reduction of sodium dialysate on occurrence 
of muscular cramp and the serum level of calcium and 
magnesium in patients undergoing hemodialysis. 
Materials and Methods  
This is a triple-blind; crossover randomized clinical trial 
study with Iranian registry of clinical trial number 
“IRCT2017040833295N1”, which is carried out on 56 CRF 
patients referred to Shahroud Imam Hossein dialysis center 
in 2017. 
Inclusion criteria were 18-75 years-old patients with ESRD, 
patients who they have been undergoing hemodialysis for at 
least two months (2-3 times a week). The exclusion criteria 
were considered as follows: 
1. The patients' blood pressure had not been controlled. 
2. Pre-dialysis blood pressure lowering medications had 
been used (the corresponding patients have prescribed blood 
pressure medication in consultation, with consulting the 
physician, after dialysis). 
3. Myocardial infarction had been occurred in the last six 
months. 
4. The ejection fraction had been less than 30%. 
5. A pacemaker had been existed. 
The medical records of patients suffering from a CRF were 
investigated. These patients underwent hemodialysis at the 
dialysis centers affiliated to Shahroud university of medical 
sciences. Then, 56 eligible patients were selected among them 
using consecutive sampling, based on the inclusion and 
exclusion criteria. It should be noted that a written consent was 
received from all of them. Subsequently, these patients were 
randomly assigned to either A or B groups using a quadruple 
blocking method. 
Data gathering tools in this study were demographic 
characteristics form (age, gender, patient’s weight), muscular 
cramp check list and measuring laboratory indices of plasma 
calcium and magnesium. Auto-analyzer Mendriy-800 was used 
to measure serum level of calcium and magnesium pre- and 
post-dialysis. 
The method of intervention was implemented in such a way 
that the control group patients (group A) were dialyzed using a 
routine method (fixed 138 mill equivalents per liter sodium 
dialysate). Moreover, the intervention group patients (group B) 
were dialyzed hemodialysis patients using the gradual 
reduction of sodium dialysate. They were dialyzed for one 
week (three sessions). The dialysis of group B was performed 
such that the reduction began with 150 mill equivalent per liter. 
This was carried out every 15 minutes per mill equivalent per 
liter, and it was continued until the concentration reached 138 
mill equivalents per liter. After wards, both groups were 
dialyzed for one week using a routine method (wash out).29 
Then, dialysis was performed using a crossover method, based 
on which the group B was dialyzed using the routine method, 
whereas group A was dialyzed using the gradual reduction of 
sodium dialysate, under three times. The type of dialysis 
machine, nurse, pump flow rate and dialyzer were constant for 
each patient during the period of study. 
Before and after the intervention, the muscular cramp was 
assessed for one or more muscles and was recorded in 
checklist. Before and after each intervention (three sessions of 
dialysis), 5cc venous clot sample were taken to measure serum 
level of calcium and magnesium. This was carried out both 
before and after the intervention (at the end of third session of 
dialysis). It is worthwhile to mention that 56 patients who were 
undergoing hemodialysis in the dialysis ward of Imam Hossein 
hospital in Shahroud were registered by the first author using 
sequential sampling among the eligible patients. Afterwards, 
they were entered to the research after understanding the 
objectives of the study and receiving a written consent. Then, 
the patients were randomly divided into two groups (group A 
and group B) using a predetermined random pattern based on 
the quadratic blocks. In this matter, the researcher distinguished 
56 series of A and B cards based on a 4-block random block 
pattern. These cards were provided to the hemodialysis ward 
supervisor in separate envelopes. In this way, the patients were 
assigned into two groups A and B, in the blind concealment 
envelope. Data were collected by a dialysis nurse who was 
unaware of the patients' allocation in the groups. 
In the current research, the patients, data collector, and data 
analyzer were unaware of the type of intervention in the groups 
A and B until the end of the study. 
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A consent form was received from all patients after 
necessary explanation of the research aims. It is worthwhile to 
mention that this study was approved by the ethics council of 
the University of Medical Sciences under code 
"IR.SHMU.REC.1396.35". 
The collected data were then analyzed through the 
descriptive statistics (e.g. mean, standard deviation, absolute 
and relative frequency) and inferential statistics (ANOVA via 
repeated measure). 
Results 
According to the results of study, mean age of the patients 
was 57.6 ± 16.7 years. In addition, most of the patients was 
man (57%), mean and standard deviation of the weight of the 
patients in the study was 65.9 ± 11.9 kg. 
The results of the study showed that the incidence rate of 
muscular cramp by routine method for one muscle was 3.8%, 
and for involvement of two or more muscles was 1.9%, and by 
the method of gradual reduction in sodium dialysate for one 
muscle was 1.9% and for two or more muscles was 7.5%. 
The therapeutic effect was compared by regression model 
of GEE, and no significant effect was observed, in other 
words, the occurrence rate of muscular cramp was not 
significantly different between the method of gradual 
reduction in sodium content of dialysis solution and routine 
method. Moreover, the arrangement of interventions has also 
no significant effect on occurrence of muscular cramp during 
dialysis (Pvalue > 0.05) (table 1). 
The results of analysis showed that there was no 
significant difference between the serum level of calcium and 
magnesium based on occurrence of muscular cramp in one or 
more muscles (table 2). 
Analysis of the data showed that the difference between 
mean serum level of calcium and magnesium pr- and post-
dialysis in the method of gradual reduction in sodium dialysate 
and routine method was not significant (table 3). 
Discussion 
The prevalence of muscular cramp in the current study by 
the routine method was 9.43%, and by the gradual reduction in 
sodium dialysate was 5.66%. The results of the study by Tang 
et al (2006) showed that the prevalence of muscular cramps by 
the routine method was 35.9%, and by the linear sodium profile 
method and ultra-filtration was 3.8%.30 The underlying 
probable reason was due to different time-periods of 
assessment, so that in the abovementioned study, the patients 
were also assessed up to four weeks after the end of the 
intervention. 
In this study, the occurrence rate of muscular cramp was 
not significantly different between the method of fixed sodium 
dialysate and gradual reduction in sodium dialysate. Whereas, 
Molaei et al (2012) investigated the effect of sodium profile 
and ultra-filtration and some common complications during 
hemodialysis, and found that sodium profile and ultra-filtration 
reduce the occurrence of complications during dialysis include 
muscular cramp, which is not in line with our results.25 This 
inconsistency might be due to limited assessment sessions of 
patients (three sessions in each intervention), whereas, in 
abovementioned study, patients were assessed six sessions for 
each intervention. The study by Iseline et al in Switzerland 
known as “using neutral sodium balance profile does not lead 
to improvement of dialysis tolerance” showed that using 
sodium profile has no effect on reduction of occurrence of 
complications during dialysis, which is in line with this study.31 
Table 1. Comparison of the prevalence of muscular cramp in both groups 
Groups Gradual reduction of sodium dialysate Control Significance level 
Prevalence of muscular cramp    





0.17  In several muscles (percentage) 
 
Table 2. Comparison of blood level of calcium and magnesium based on muscular cramp in one or more muscles in hemodialysis patients 
Muscular cramp Variable 
Serum level of calcium 
Statistical indices 
Serum level of magnesium 
Statistical indices 
Mean (SD) Mean (SD) 
One muscle 
with 9.4 (0.2)  0.86=t  
 94 =df  
 0.39= Pvalue  
3 (0.7)  0.29 = t  
 94= df  
 0.7=Pvalue  
without 9.07 (0.66) 2.9 (0.44) 
Several muscles 
with 9.04 (0.8)  0.14=t  
 94=df  
 0.9=P  
2.82 (0.46)  0.52=t  
 94=df  
 0.6=P  
without 9.08 (0.65) 2.9 (0.45) 
 
Table 3. Comparison of mean differences in serum level of calcium and magnesium pre- and post-dialysis in both groups 
Groups Mean differences and SD of serum level of calcium Mean differences and SD of serum level of magnesium 
Control 0.43 ± 0.77 -0.26 ± 0.44 
Gradual reduction of sodium dialysate 0.45 ± 0.69 -0.34 ± 0.49 
Statistical indices 
t = 0.13 
df = 104 
P = 0.89 
t = 0.933 
df = 104 
P = 0.35 
SD. Standard deviation 
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The results of this study showed that mean muscular cramp 
and involvement of one or more muscles in intervention group 
in comparison to control group has no significant relationship 
with calcium concentration of the patients. In the study by 
Khoramverdi et al (2011) entitled “comparison of the effect of 
calcium and placebo in muscular cramp in pregnant women” 
and conducted on 57 pregnant women with muscular cramp 
and the severity of cramp in patients in four weeks during 
treatment. The results showed that calcium is very effective in 
attenuating muscular cramp.32 Sohrabvand et al (2006) 
investigated the prevalence of muscular cramp in pregnancy 
period and the effect of supplement therapy on it. This study 
was conducted on 104 individuals with muscular cramp, and 
the results showed that calcium supplement is very effective in 
attenuating muscular cramp.33 The probable reason for this 
inconsistency is the intervention type, so that in both 
interventions, calcium supplement was administered to 
patients, whereas, in the current study, the effect of gradual 
reduction of sodium dialysate.  
In the current study, the incidence of muscular cramp in 
one or more muscles was not significantly different between 
intervention group and control group. In addition, no 
significant difference was observed between serum magnesium 
levels between both groups. In the study by Dahle, 73 patients 
with calf cramp were assessed in a prospective and double-
blinded randomized design, and the serum magnesium level 
and daily excretion of it were firstly recorded, and then the oral 
magnesium or placebo were administered to patients for three 
weeks. The results showed that serum level of magnesium level 
at the time of occurrence of calf cramps is less than patients 
without cramp, and also magnesium therapy is effective in a 
wide spectrum of pathologic disorders such as cramp.17 The 
probable reasons for this inconsistency are difference in study 
population and the type of intervention. 
The results of the current study showed that gradual 
reduction in sodium dialysate had no role in reducing the 
muscular cramp, serum level of calcium and magnesium of 
patients undergoing hemodialysis. Although, more studies are 
needed to confirm or reject this finding, significant occurrence 
of muscular cramp during dialysis is one of the issues which 
should be considered by nurses caring these patients, and also 
they should make attempts to reduce it. 
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